RESULTS	A significant reduction was observed only in the first 3 months of follow-up ( artesunate-primaquine vs control , -58 % [ P = .004 ] ; artesunate-primaquine vs artesunate , -49 % [ P = .031 ] ) with little difference thereafter .\